B

Bioharmony Therapeutics

10 employees

Bioharmony Therapeutics is developing next-gen antimicrobial therapies for lethal multi-drug resistant bacterial infections.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Date founded

2016

Funding rounds raised

Total raised

$100K

from 2 investors over 2 rounds

B

Bioharmony Therapeutics raised undisclosed on January 1, 2019

Investors: Catalytic Impact Foundation

B

Bioharmony Therapeutics raised $100K on December 18, 2017

Investors: Accelerate NY Seed Fund

FAQ